Evolving epidemiology of invasive Haemophilus infections in the post-vaccination era: results from a long-term population-based study.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
MetadataShow full item record
CitationClin Microbiol Infect 2012, 18(9):918-23
AbstractHistorically, Haemophilus influenzae (Hi) serotype b (Hib) caused most invasive Haemophilus infections worldwide, mainly in children. In 1989 routine childhood vaccination against Hib was initiated in Iceland. We conducted a population-based study of all patients in the country with Haemophilus spp. isolated from sterile sites (n = 202), from 1983 to 2008. Epidemiology, clinical characteristics of the infections and serotypes of the isolates were compared during the pre-vaccination (1983-1989) and post-vaccination era (1990-2008). Following the vaccination, the overall incidence of Hib decreased from 6.4 to 0.3/100,000 per year (p <0.05) whereas the incidence did not change significantly for infections caused by Haemophilus sensu lato not serotype b, hereafter referred to as non-type b Hi (0.9 vs 1.2, respectively). The most frequent diagnosis prior to 1990 was meningitis caused by Hib, which was subsequently replaced by pneumonia and bacteraemia caused by non-type b Hi. Most commonly, non-type b Hi were non-typeable (NTHi; 40/59), followed by Hi serotype f (14/59) and Hi serotype a (3/59). Pregnancy was associated with a markedly increased susceptibility to invasive Haemophilus infections (RR 25.7; 95% CI 8.0-95.9, p <0.0001) compared with non-pregnant women. The case fatality rate for Hib was 2.4% but 14% for non-type b Hi, highest at the extremes of age. Hib vaccination gives young children excellent protection and decreases incidence in the elderly due to herd effect in the community. Replacement with other species or serotypes has not been noted. Pregnant women are an overlooked risk group.
RightsArchived with thanks to Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
- Changing epidemiology of invasive Haemophilus influenzae in Ontario, Canada: evidence for herd effects and strain replacement due to Hib vaccination.
- Authors: Adam HJ, Richardson SE, Jamieson FB, Rawte P, Low DE, Fisman DN
- Issue date: 2010 May 28
- Pediatric invasive Haemophilus influenzae infections in Israel in the era of Haemophilus influenzae type b vaccine: a nationwide prospective study.
- Authors: Bamberger EE, Ben-Shimol S, Abu Raya B, Katz A, Givon-Lavi N, Dagan R, Srugo I, Israeli Pediatric Bacteremia and Meningitis Group.
- Issue date: 2014 May
- Invasive Haemophilus influenzae infections in Germany: impact of non-type b serotypes in the post-vaccine era.
- Authors: Kalies H, Siedler A, Gröndahl B, Grote V, Milde-Busch A, von Kries R
- Issue date: 2009 Apr 20
- Invasive Haemophilus influenzae disease in Utah children: an 11-year population-based study in the era of conjugate vaccine.
- Authors: Bender JM, Cox CM, Mottice S, She RC, Korgenski K, Daly JA, Pavia AT
- Issue date: 2010 Apr 1
- Invasive infections caused by haemophilus influenzae serotypes in twelve Canadian IMPACT centers, 1996-2001.
- Authors: McConnell A, Tan B, Scheifele D, Halperin S, Vaudry W, Law B, Embree J, of The Canadian Immunization Monitoring Program, ACTive (IMPACT).
- Issue date: 2007 Nov